Medpace Holdings, Inc. (MEDP) earnings date, results and what the price requires
Nasdaq · SEC CIK 0001668397 · SEC filings checked Oct 18, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 22, 2026 | $707.3M | $121.4M | $4.25 | Filing |
| Mar 31, 2026 | Apr 22, 2026 | $706.6M | $123.9M | $4.28 | Filing |
| Dec 31, 2025 | Feb 9, 2026 | $708.5M | $135.1M | $4.65 | Filing |
| Sep 30, 2025 | Oct 22, 2025 | $659.9M | $111.1M | $3.86 | Filing |
| Jun 30, 2025 | Jul 21, 2025 | $603.3M | $90.3M | $3.10 | Filing |
| Mar 31, 2025 | Apr 21, 2025 | $558.6M | $114.6M | $3.67 | Filing |
| Dec 31, 2024 | Feb 10, 2025 | $536.6M | $117.0M | $3.67 | Filing |
| Sep 30, 2024 | Oct 21, 2024 | $533.3M | $96.4M | $3.01 | Filing |
What would Medpace Holdings, Inc. have to report for its valuation to change?
At $618.47, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about 25.4% a year, to $52.87. On that path the next quarter needs diluted EPS near $4.84, against $3.86 in the quarter ended Sep 30, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | 25.4% | 25.4% |
| EPS needed in final year | $52.87 | $52.87 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. MEDP goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.